sur ZetrOZ Systems
ZetrOZ Systems to Showcase Innovative Ultrasound Device at CATS 2024 Symposium
ZetrOZ Systems will present its FDA-cleared sam® wearable ultrasound unit at the College Athletic Trainers' Society (CATS) 2024 Symposium, which will take place from May 15-18 at The Orleans Hotel in Las Vegas. The device is designed to accelerate soft tissue repair, aligning with CATS's mission of enhancing care in intercollegiate athletics.
At the symposium, ZetrOZ Systems aims to share their sustained acoustic medicine technology, which has been supported by over 40 peer-reviewed studies, demonstrating significant advantages in healing and pain management. The technology provides a non-invasive option that enhances blood flow and speeds up recovery, allowing athletes to return to activity without the need for surgery or heavy reliance on pain medication.
George Lewis, CEO of ZetrOZ Systems, expressed enthusiasm about the collaboration with CATS and the opportunity to promote advanced treatment solutions to frontline sports medicine professionals. The company’s involvement in the symposium underscores its commitment to improving athlete care through innovative medical technology.
R. P.
Copyright © 2024 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de ZetrOZ Systems